Corporate Banner
Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Prize Awarded to New Membrane Technology from Evonik

Published: Thursday, December 05, 2013
Last Updated: Thursday, December 05, 2013
Bookmark and Share
Biogas processing considerably more efficient and environmentally friendly.

With a level of purity approaching 99 percent, SEPURAN® Green high performance polymers from Evonik Industries make biogas processing much more efficient.

For this achievement, the company has now received the 2013 German Innovation Prize for Climate and the Environment in the "Environmentally friendly technologies" category.

The prize is awarded by the Federal Ministry for the Environment, Nature Conservation and Nuclear Safety (BMU) and the Federation of German Industry (BDI). Dr. Dahai Yu, responsible for the Specialty Materials Segment in the Executive Board: "Innovations are a major contribution towards overcoming the challenges of the future. This also includes securing energy supplies practically from economical, ecological, and social aspects. With SEPURAN® Green, Evonik shows what the chemical industry can do to make this happen."

Biogas, which consists mainly of the gases CO2 and methane, is regarded as an environmentally friendly form of energy. Before biogas can be fed into the natural gas grid it requires a considerable amount of processing and cleaning.

The SEPURAN® Green membrane technology from Evonik now makes this process much more efficient and environmentally friendly.

"Our SEPURAN® membranes are made from a high performance polymer that we developed in-house," says Dr. Goetz Baumgarten, Head of the SEPURAN® business. "This polymer gives the membrane a particular property so that it is especially able to distinguish between methane and CO2."

But the membrane alone is not enough. A conditioning process for biogas, tailored especially to the membranes from Evonik, makes optimum use of their separation properties: In a three-stage process, the methane can be concentrated out of the crude gas with just one compressor and an especially high methane yield. In addition, the methane-rich gas does not have to be compressed further before it is fed into the natural gas grid.

This membrane process is up to 20 percent more energy efficient than alternative methods. Besides, no auxiliary chemicals are required. No waste or wastewater are produced.

Evonik initially trialed SEPURAN® Green in a test plant beside the Vöckla River in Neukirchen, Austria. Since then, several biogas processing plants using SEPURAN® Green technology have been put into operation. Evonik is continuing to develop the SEPURAN® technology for new applications, such as separating hydrogen and recovering nitrogen from compressed air.

With the German Innovation Prize for Climate and the Environment the Federal Ministry for the Environment, Nature Conservation and Nuclear Safety (BMU) and the Federation of German Industry (BDI) acknowledge German industry's commitment to climate and environmental protection. This year was the fourth time that the prize has been awarded. The winners were chosen from among 97 contestants in five categories.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,300+ scientific posters on ePosters
  • More Than 4,900+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Evonik Commences Isophorone Facilities in China
Investment exceeding €100 million targets dynamic markets in Asia.
Thursday, May 22, 2014
Biotech Company Algal Scientific Receives Investment Funding
Evonik, part of an investors’ consortium that is investing more than US$3 million in Series A financing round, is investing in the startup.
Monday, April 28, 2014
Evonik Expanding Global Isophorone and Isophorone Diamine Capacities
New production plants to be completed in early 2014, significantly increasing the total capacities of IP and IPD.
Friday, November 15, 2013
Evonik Opens a New Plant in Argentina
With an annual capacity of over 60,000 metric tons, the new production plant will supply ready-to-use alkoxides for use as catalysts in biodiesel production from renewable raw materials.
Monday, October 21, 2013
Scientific News
Breakthrough Flu Vaccine Inhibited by Pre-existing Antibodies
Universal truths – how existing antibodies are sabotaging the most promising new human flu vaccines.
Researchers Develop Software That Could Facilitate Drug Development
AptaTRACE can identify aptamers, potentially speed drug advancement.
Gene Therapy for Metabolic Liver Diseases
Researchers have tested gene therapy in pigs from hereditary tyrosinemia type 1, with corrected liver cells being transplanted into the diseased liver.
Zika Vaccine Candidates Show Promise
Two experimental vaccines have shown promise against a major viral strain responsible for the Brazilian Zika outbreak.
New Medication Shows Promise Against Liver Fibrosis in Animal Studies
Liver fibrosis is a gradual scarring of the liver that puts people at risk for progressive liver disease and liver failure.
Raw Eggs Deemed Safe to Eat
A report published today by the Advisory Committee on the Microbiological Safety of Food (ACMSF) into egg safety has shown a major reduction in the risk from salmonella in UK eggs.
Monitoring TTX Toxin in Shellfish
In a number of small studies, mussels and oysters from the eastern and northern part of the Oosterschelde in Holland were found to contain tetrodotoxin (TTX).
Gene Terapy for Muscle Wasting Developed
New gene therapy could save millions of people suffering from muscle wasting disease.
NIH Begins Yellow Fever Vaccine Trial
NIH has initiated an early-stage clinical trial of a vaccine to protect against yellow fever.
Gene-Editing 'Toolbox' Targets Multiple Genes Simultaneously
Researchers have designed a system that modifies, or edits, multiple genes in a genome at once while minimising unintentional effects.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,300+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,900+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!